Drug maker tests new injection method in healthy people
NCT ID NCT07446101
Summary
This early-stage study aims to compare how the body processes an experimental drug called mirikizumab when given as one injection versus two injections under the skin. It will involve 450 healthy volunteers to check the safety and how the drug moves through the body. The main goal is to see if the two injection methods deliver the drug similarly, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Axis Clinicals LLC
Dilworth, Minnesota, 56560, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
Madison, Wisconsin, 53704, United States
Contact Phone: •••-•••-••••
Contact
-
Worldwide Clinical Trials, Inc.
San Antonio, Texas, 78217, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.